|
"tang yc"的相關文件
顯示項目 1-12 / 12 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-01 |
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
|
Tang, YC;Ou, JJ;Hsu, SC;Huang, CH;Lin, LM;Chang, HH;Wang, YH;Huang, ZT;Sun, M;Liu, KJ;Hung, YM;Lai, CY;Shih, C;Chen, CT;Chang, JY;Hsieh, HP;Jiaang, WT;Kuo, CC |
| 國家衛生研究院 |
2024-11-26 |
Development of potent and selective inhibitors of methylenetetrahydrofolate dehydrogenase 2 for targeting acute myeloid leukemia: Sar, structural insights, and biological characterization
|
Chang, HH;Lee, LC;Hsu, T;Peng, YH;Huang, CH;Yeh, TK;Lu, CT;Huang, ZT;Hsueh, CC;Kung, FC;Lin, LM;Huang, YC;Wang, YH;Li, LH;Tang, YC;Chang, L;Hsieh, CC;Jiaang, WT;Kuo, CC;Wu, SY |
| 國家衛生研究院 |
2023-02-28 |
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
|
Tang, YC;Chuang, YJ;Chang, HH;Juang, SH;Yen, GC;Chang, JY;Kuo, CC |
| 國家衛生研究院 |
2021-12-14 |
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
|
Tang, YC;Chang, HH;Chen, HH;Yao, JY;Chen, YT;Chuang, YJ;Chang, JY;Kuo, CC |
| 國家衛生研究院 |
2021-03-11 |
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
|
Tang, YC;Hsiao, JR;Jiang, SS;Chang, JY;Chu, PY;Liu, KJ;Fang, HL;Lin, LM;Chen, HH;Huang, YW;Chen, YT;Tsai, FY;Lin, SF;Chuang, YJ;Kuo, CC |
| 國家衛生研究院 |
2018-04 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
|
Lin, SY;Yeh, TK;Song, JS;Hung, MS;Cheng, MF;Liao, FY;Li, AS;Cheng, SY;Lin, LM;Chiu, CH;Wu, MH;Lin, YJ;Hsiao, W;Sun, M;Wang, YH;Huang, CH;Tang, YC;Chang, HH;Huang, ZT;Chao, YS;Shih, C;Pan, SL;Wu, SY;Kuo, CC;Ueng, SH |
| 國家衛生研究院 |
2017-12 |
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells
|
Chen, HH;Chang, HH;Chang, JY;Tang, YC;Cheng, YC;Lin, LM;Cheng, SY;Huang, CH;Sun, MW;Chen, CT;Kuo, CC |
| 國家衛生研究院 |
2015-07-10 |
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation
|
Lee, CH;Pan, KL;Tang, YC;Tsai, MH;Cheng, AJ;Shen, MY;Cheng, YM;Huang, TT;Lin, P |
| 國家衛生研究院 |
2015-04 |
IL-1beta promotes malignant transformation and tumor aggressiveness in oral cancer
|
Lee, CH;Chang, JS;Syu, SH;Wong, TS;Chan, JY;Tang, YC;Yang, ZP;Yang, WC;Chen, CT;Lu, SC;Tang, PH;Yang, TC;Chu, PY;Hsiao, JR;Liu, KJ |
| 中山醫學大學 |
2014 |
Polyphenol-rich extract of Nelumbo nucifera leaves inhibits alcohol-induced steatohepatitis via reducing hepatic lipid accumulation and anti-inflammation in C57BL/6J mice.
|
Tang, CC; Lin, WL; Lee, YJ; Tang, YC; Wang, CJ |
| 臺北醫學大學 |
2008 |
A pilot study for circadian gene disturbance in dementia patients.
|
胡朝榮; Liu HC; Hu CJ; Tang YC; Chang JG |
| 臺北醫學大學 |
2006 |
Extended-spectrum ß-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan.
|
劉永慶; Yan JJ; Hsueh PR; Lu JJ; Chang FY; Shyr JM; Wan JH; Liu YC; Chuang YC; Tang YC; Tsao SM; Wu HH; Wang LS; Lin TP; Wu HM; Chen HM; Wu JJ |
顯示項目 1-12 / 12 (共1頁)
1
每頁顯示[10|25|50]項目
|
